Associations between the Drug Burden Index, Potentially Inappropriate Medications and Quality of Life in Residential Aged Care
- 189 Downloads
Inappropriate polypharmacy may negatively impact the quality of life of residents in aged care facilities, but it remains unclear which medications may influence this reduced quality of life.
The objective of this study was to examine whether the Drug Burden Index and potentially inappropriate medications were associated with quality of life in older adults living in residential care with a high prevalence of cognitive impairment and dementia.
We conducted cross-sectional analyses of 541 individuals recruited from 17 residential aged care facilities in Australia in the Investigating Services Provided in the Residential Environment for Dementia (INSPIRED) study. Quality of life was measured using the EuroQol Five Dimensions Questionnaire (a measure of generic quality of life) and the Dementia Quality of Life Questionnaire completed by the participant or a proxy.
In the 100 days prior to recruitment, 83.1% of the participants received at least one anticholinergic or sedative medication included in the Drug Burden Index and 73.0% received at least one potentially inappropriate medication according to the Beers Criteria. Multi-level linear models showed there was a significant association between a higher Drug Burden Index and lower quality of life according to the EuroQol Five Dimensions Questionnaire [β (standard error): − 0.034 (0.012), p = 0.006] after adjustment for potential confounding factors. Increasing numbers of potentially inappropriate medications were also associated with lower EuroQol Five Dimensions Questionnaire scores [− 0.030 (0.010), p = 0.003] and Dementia Quality of Life Questionnaire-Self-Report-Utility scores [− 0.020 (0.009), p = 0.029]. Exposure to both Drug Burden Index-associated medications and potentially inappropriate medications was associated with lower Dementia Quality of Life Questionnaire-Self-Report-Utility scores [− 0.034 (0.017), p = 0.049].
Exposure to anticholinergic and sedative medications and potentially inappropriate medications occurred in over three-quarters of a population of older adults in residential care and was associated with a lower quality of life.
The authors sincerely thank the INSPIRED study participants and their family members for their participation and interest in the study. The assistance of facility staff, care worker researchers, facility pharmacists and data collectors in each state is gratefully acknowledged. We thank members of the study team Mrs Anne Whitehouse, Mrs Angela Basso, Ms Keren McKenna, Dr. Wendy Shulver and Dr. Rebecca Bilton for their input into the INSPIRED study management, data collection and data coordination.
Compliance with Ethical Standards
Conflict of interest
Suzanne Dyer was employed in the development of the Clinical Practice Guidelines for Dementia in Australia, which includes recommendations relating to the use of pharmaceuticals in dementia. Stephanie Harrison, Lisa Kouladjian O’Donnell, Clare Bradley, Rachel Milte, Emmanuel Gnanamanickam, Enwu Liu, Sarah Hilmer and Maria Crotty have no conflicts of interest directly relevant to the content of this article.
All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional committee (Flinders Social and Behavioural Research Ethics Committee: Approval Nos. 6732 and 6753). Informed consent was obtained from all individual participants included in the study (self-consent or proxy) as approved by the ethics committee.
- 3.Department of Health and Ageing. Evaluation of the impact of accreditation on the delivery of quality of care and quality of life to residents in Australian Government subsidised residential aged care homes. 2007. http://apo.org.au/node/8564. [Accessed 15 Dec 2017].
- 5.Banerjee S, Samsi K, Petrie CD, Alvir J, Treglia M, Schwam EM, et al. What do we know about quality of life in dementia? A review of the emerging evidence on the predictive and explanatory value of disease specific measures of health related quality of life in people with dementia. Int J Geriatr Psychiatry. 2009;24(1):15–24. https://doi.org/10.1002/gps.2090.CrossRefPubMedGoogle Scholar
- 6.AIHW. Residential aged care and home care 2013–14. 2014. http://www.aihw.gov.au/aged-care/residential-and-home-care-2013-14/. [Accessed 15 Dec 2017].
- 17.Mulhern B, Rowen D, Brazier J, Smith S, Romeo R, Tait R, et al. Development of DEMQOL-U and DEMQOL-PROXY-U: generation of preference-based indices from DEMQOL and DEMQOL-PROXY for use in economic evaluation. Health Technol Assess. 2013;17(5):v–xv–1–140. https://doi.org/10.3310/hta17050.CrossRefGoogle Scholar
- 18.Devlin N, Shah KK, Feng Y, Mulhern B, Van Hout B. Valuing health-related quality of life: an EQ-5D-5L value set for England. HEDS Discussion Paper Series (1602). Sheffield: University of Sheffield: Health Economics and Decision Science, School of Health and Related Research (ScHARR); 2016.Google Scholar
- 21.Bosboom PR, Alfonso H, Almeida OP, Beer C. Use of potentially harmful medications and health-related quality of life among people with dementia living in residential aged care facilities. Dement Geriatr Cogn Dis Extra. 2012;2(1):361–71. https://doi.org/10.1159/000342172.CrossRefPubMedPubMedCentralGoogle Scholar
- 24.Oremus M, Tarride JE, Clayton N, Raina P, Canadian Willingness-to-Pay Study Group. Health utility scores in Alzheimer’s disease: differences based on calculation with American and Canadian preference weights. Value Health. 2014;17(1):77–83. https://doi.org/10.1016/j.jval.2013.10.009.CrossRefPubMedGoogle Scholar
- 28.Garcia-Gollarte F, Baleriola-Julvez J, Ferrero-Lopez I, Cuenllas-Diaz A, Cruz-Jentoft AJ. An educational intervention on drug use in nursing homes improves health outcomes resource utilization and reduces inappropriate drug prescription. J Am Med Dir Assoc. 2014;15(12):885–91. https://doi.org/10.1016/j.jamda.2014.04.010.CrossRefPubMedGoogle Scholar
- 30.Dalleur O, Boland B, Losseau C, Henrard S, Wouters D, Speybroeck N, et al. Reduction of potentially inappropriate medications using the STOPP criteria in frail older inpatients: a randomised controlled study. Drugs Aging. 2014;31(4):291–8. https://doi.org/10.1007/s40266-014-0157-5.CrossRefPubMedGoogle Scholar
- 31.Pitkala KH, Juola AL, Kautiainen H, Soini H, Finne-Soveri UH, Bell JS, et al. Education to reduce potentially harmful medication use among residents of assisted living facilities: a randomized controlled trial. J Am Med Dir Assoc. 2014;15(12):892–8. https://doi.org/10.1016/j.jamda.2014.04.002.CrossRefPubMedGoogle Scholar
- 33.Crotty M, Whitehead C, Rowett D, Halbert J, Weller D, Finucane P, et al. An outreach intervention to implement evidence based practice in residential care: a randomized controlled trial [ISRCTN67855475]. BMC Health Serv Res. 2004;4(1):6. https://doi.org/10.1186/1472-6963-4-6.CrossRefPubMedPubMedCentralGoogle Scholar
- 35.Skoldunger A, Fastbom J, Wimo A, Fratiglioni L, Johnell K. Impact of inappropriate drug use on hospitalizations, mortality, and costs in older persons and persons with dementia: findings from the SNAC study. Drugs Aging. 2015;32(8):671–8. https://doi.org/10.1007/s40266-015-0287-4.CrossRefPubMedPubMedCentralGoogle Scholar
- 36.Diaz-Redondo A, Rodriguez-Blazquez C, Ayala A, Martinez-Martin P, Forjaz MJ, Spanish Research Group on Quality of Life. EQ-5D rated by proxy in institutionalized older adults with dementia: psychometric pros and cons. Geriatr Gerontol Int. 2014;14(2):346–53. https://doi.org/10.1111/ggi.12108.CrossRefPubMedGoogle Scholar